Search research articles
Contact Us
Filters
Showing results (71-80 of 197) with videos related to
Page
of 20
Sort By:
European Journal of Clinical Pharmacology
|
September 11, 2001
Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population
J Larsen, M Andersen, J Kragstrup, et al.
Journal of Hypertension
|
May 1, 1989
Plasma noradrenaline response to a multistage exercise test in young men at increased risk of developing essential hypertension
J R Nielsen, L F Gram, P K Pedersen
Psychopharmacology
|
January 1, 1984
Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants
P Bech, P Allerup, N Reisby, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1988
In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver
S V Otton, R U Brinn, L F Gram
Pharmacology & Toxicology
|
January 1, 1988
Plasma noradrenaline levels in young subjects at increased risk of developing essential hypertension. Response to a multistage exercise test
J R Nielsen, L F Gram, P K Pedersen
British Journal of Clinical Pharmacology
|
May 1, 1989
Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark
A Drøhse, L Bathum, K Brøsen, et al.
Psychopharmacology
|
January 1, 1985
Mianserin protein binding in serum and plasma from healthy subjects and patients with depression and rheumatoid arthritis
C B Kristensen, L F Gram, P Kragh-Sørensen
Clinical Physiology (Oxford, England)
|
January 1, 1985
Antidepressive agents in the treatment of diabetic neuropathy
B Kvinesdal, J Molin, A Frøland, et al.
Ugeskrift for Laeger
|
September 26, 1983
[Imipramine in the treatment of painful diabetic neuropathy of the extremities]
B Kvinesdal, J Molin, A Frøland, et al.
JAMA
|
April 6, 1984
Imipramine treatment of painful diabetic neuropathy
B Kvinesdal, J Molin, A Frøland, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 197) with videos related to
Sort By:
Page
of 20
European Journal of Clinical Pharmacology
|
September 11, 2001
Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population
J Larsen, M Andersen, J Kragstrup, et al.
Journal of Hypertension
|
May 1, 1989
Plasma noradrenaline response to a multistage exercise test in young men at increased risk of developing essential hypertension
J R Nielsen, L F Gram, P K Pedersen
Psychopharmacology
|
January 1, 1984
Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants
P Bech, P Allerup, N Reisby, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1988
In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver
S V Otton, R U Brinn, L F Gram
Pharmacology & Toxicology
|
January 1, 1988
Plasma noradrenaline levels in young subjects at increased risk of developing essential hypertension. Response to a multistage exercise test
J R Nielsen, L F Gram, P K Pedersen
British Journal of Clinical Pharmacology
|
May 1, 1989
Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark
A Drøhse, L Bathum, K Brøsen, et al.
Psychopharmacology
|
January 1, 1985
Mianserin protein binding in serum and plasma from healthy subjects and patients with depression and rheumatoid arthritis
C B Kristensen, L F Gram, P Kragh-Sørensen
Clinical Physiology (Oxford, England)
|
January 1, 1985
Antidepressive agents in the treatment of diabetic neuropathy
B Kvinesdal, J Molin, A Frøland, et al.
Ugeskrift for Laeger
|
September 26, 1983
[Imipramine in the treatment of painful diabetic neuropathy of the extremities]
B Kvinesdal, J Molin, A Frøland, et al.
JAMA
|
April 6, 1984
Imipramine treatment of painful diabetic neuropathy
B Kvinesdal, J Molin, A Frøland, et al.
Page
of 20